Chief Financial Officer · NEUROCRINE BIOSCIENCES INC · Common Stock
Side
SELL
Value
$363K
Shares
2,311
Price
$157.2
Executed
Sep 14, 2026
Disclosed
Sep 15, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 14 executedSep 15, 2026 disclosed
NBIX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Abernethy Matt filed this Form 4 reporting a open-market sale of NBIX on Sep 14, 2026. It became public on Sep 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Abernethy Mattcik:0001724097
Issuer
NEUROCRINE BIOSCIENCES INCcik:0000914475
Revision history · 0
No field has changed since this record was first ingested.
